SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001326190-24-000012
Filing Date
2024-03-27
Accepted
2024-03-27 16:10:24
Documents
5
Effectiveness Date
2024-03-27

Document Format Files

Seq Description Document Type Size
1 S-8 tmb-20240307xs8.htm S-8 72423
2 EX-5.1 tmb-20240307xex5d1.htm EX-5.1 8423
3 EX-23.1 tmb-20240307xex23d1.htm EX-23.1 2584
4 EX-FILING FEES tmb-20240307xexfilingfees.htm EX-FILING FEES 20352
5 GRAPHIC tmb-20240307xex5d1001.jpg GRAPHIC 4765
  Complete submission text file 0001326190-24-000012.txt   111760
Mailing Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878
Business Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878 2406541450
Altimmune, Inc. (Filer) CIK: 0001326190 (see all company filings)

IRS No.: 202726770 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-278273 | Film No.: 24790714
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)